A detailed history of Barclays PLC transactions in Augmedix, Inc. stock. As of the latest transaction made, Barclays PLC holds 18,372 shares of AUGX stock, worth $43,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,372
Previous 18,372 -0.0%
Holding current value
$43,174
Previous $43,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$0.89 - $2.35 $13,297 - $35,111
14,941 Added 435.47%
18,372 $43,000
Q2 2024

Aug 14, 2024

BUY
$0.75 - $4.18 $2,423 - $13,505
3,231 Added 1615.5%
3,431 $3,000
Q1 2024

May 15, 2024

SELL
$3.2 - $5.83 $59,696 - $108,758
-18,655 Reduced 98.94%
200 $1,000
Q4 2023

Feb 15, 2024

SELL
$4.34 - $5.93 $15,020 - $20,523
-3,461 Reduced 15.51%
18,855 $110,000
Q3 2023

Nov 07, 2023

BUY
$3.91 - $5.3 $87,255 - $118,274
22,316 New
22,316 $115,000

Others Institutions Holding AUGX

About Augmedix, Inc.


  • Ticker AUGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,421,200
  • Market Cap $87.9M
  • Description
  • Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes...
More about AUGX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.